Szakmai blog
Blog
Szakértői betekintések és gondolatok az egészségügyi technológiaértékelés területéről
Kiemelt
Many digital health companies focus heavily on technology development but underestimate the importance of reimbursement planning. Without a clear strategy for evidence generation, target populations, and payer expectations, even strong products may struggle to achieve adoption. Understanding the most common reimbursement mistakes can help companies avoid delays, reduce risk, and improve their chances of successful market access.
2026. május 11.
4 min read
By AdminEarly Health Technology Assessment (HTA) can help startups avoid costly mistakes, identify the right target market, plan stronger evidence generation, and improve reimbursement readiness. By considering clinical, economic, and market access factors early in development, companies can reduce risk and increase their chances of successful market entry.
2026. április 20.
5 min
By AdminTovább